IL17A and breast cancer: Specifically, DEMs were mainly enriched in the TGF-beta signaling pathway, drug metabolism-cytochrome P450 pathway, cell cycle, p53 signaling pathway, breast cancer, TNF signaling pathway, IL-17 signaling pathway, and hippo signaling pathway (Fig. 3A).